TOPACIO/Keynote-162: Niraparib + pembrolizumab in patients (pts) with metastatic triple-negative breast cancer (TNBC), a phase 2 trial.

标题
TOPACIO/Keynote-162: Niraparib + pembrolizumab in patients (pts) with metastatic triple-negative breast cancer (TNBC), a phase 2 trial.
作者
关键词
-
出版物
JOURNAL OF CLINICAL ONCOLOGY
Volume 36, Issue 15_suppl, Pages 1011-1011
出版商
American Society of Clinical Oncology (ASCO)
发表日期
2018-09-05
DOI
10.1200/jco.2018.36.15_suppl.1011

向作者/读者发起求助以获取更多资源

Find Funding. Review Successful Grants.

Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.

Explore

Find the ideal target journal for your manuscript

Explore over 38,000 international journals covering a vast array of academic fields.

Search